STUDY SEARCH RESULTS

1 study found for your search request:  5592-127

Posaconazole (MK-5592) intravenous and oral in children (<2 years) with invasive fungal infection (M...
Condition: Invasive Fungal Infection
Minimum Age: 1 days, Maximum Age: 2 years
Gender: All
Study ID: NCT04665037
Status: Recruiting
Has Enrolling Locations in US or Canada




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site